Valeant’s Latest Legal Threat Could Be Especially Costly
Valeant Pharmaceuticals International Inc. signage is displayed on a monitor on the floor of the New York Stock Exchange. (Photographer: Michael Nagle/Bloomberg)

Valeant’s Latest Legal Threat Could Be Especially Costly

(Bloomberg) -- Valeant Pharmaceuticals International Inc. has been selling assets, paying down debt and riding a recovery of its shares from their lowest point last spring. But one big uncertainty ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.